Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design. (2019)

First Author: Pereira SGT
Attributed to:  Engineering Multi-functional Nanomaterials to Treat Metastatic Cancer funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.8b01257

PubMed Identifier: 30802065

Publication URI: http://europepmc.org/abstract/MED/30802065

Type: Journal Article/Review

Volume: 16

Parent Publication: Molecular pharmaceutics

Issue: 4

ISSN: 1543-8384